Searching for Biomarkers

Katrina Burgos | July 1, 2014

Chemistry Cancer Research Harper Feature

When it comes to a cancer diagnosis, timing can be everything. An early diagnosis can make a big difference when it comes to treatment possibilities. Pancreatic Ductile Adenocarcinoma (PDAC) has a 5 year survival rate of 6% according to Dr. Reginald Hill, Archibald Assistant Professor of Cancer Biology at the University of Notre Dame. Improving detection rates is a crucial step in changing that statistic.


“The biggest clinical challenges that we face with pancreatic cancer are early detection and chemoresistance. My research focuses on both sides,” Hill said.

Read the full story at Haper Cancer Research Institute

 by Daily Domer Staff

Posted In: Editor's Picks